These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9781881)

  • 1. The effect of oxygenated mycolic acid composition on cell wall function and macrophage growth in Mycobacterium tuberculosis.
    Yuan Y; Zhu Y; Crane DD; Barry CE
    Mol Microbiol; 1998 Sep; 29(6):1449-58. PubMed ID: 9781881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MMAS-1, the branch point between cis- and trans-cyclopropane-containing oxygenated mycolates in Mycobacterium tuberculosis.
    Yuan Y; Crane DC; Musser JM; Sreevatsan S; Barry CE
    J Biol Chem; 1997 Apr; 272(15):10041-9. PubMed ID: 9092547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the epoxide hydrolase EphD on the metabolism of mycolic acids in mycobacteria.
    Madacki J; Laval F; Grzegorzewicz A; Lemassu A; Záhorszká M; Arand M; McNeil M; Daffé M; Jackson M; Lanéelle MA; Korduláková J
    J Biol Chem; 2018 Apr; 293(14):5172-5184. PubMed ID: 29472294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A common mechanism for the biosynthesis of methoxy and cyclopropyl mycolic acids in Mycobacterium tuberculosis.
    Yuan Y; Barry CE
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):12828-33. PubMed ID: 8917504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterium bovis BCG genes involved in the biosynthesis of cyclopropyl keto- and hydroxy-mycolic acids.
    Dubnau E; Lanéelle MA; Soares S; Bénichou A; Vaz T; Promé D; Promé JC; Daffé M; Quémard A
    Mol Microbiol; 1997 Jan; 23(2):313-22. PubMed ID: 9044265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A point mutation in the mma3 gene is responsible for impaired methoxymycolic acid production in Mycobacterium bovis BCG strains obtained after 1927.
    Behr MA; Schroeder BG; Brinkman JN; Slayden RA; Barry CE
    J Bacteriol; 2000 Jun; 182(12):3394-9. PubMed ID: 10852869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis. Identification and functional analysis of CMAS-2.
    George KM; Yuan Y; Sherman DR; Barry CE
    J Biol Chem; 1995 Nov; 270(45):27292-8. PubMed ID: 7592990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of methoxymycolic acid production by Mycobacterium bovis BCG vaccines.
    Belley A; Alexander D; Di Pietrantonio T; Girard M; Jones J; Schurr E; Liu J; Sherman DR; Behr MA
    Infect Immun; 2004 May; 72(5):2803-9. PubMed ID: 15102790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiacetazone, an antitubercular drug that inhibits cyclopropanation of cell wall mycolic acids in mycobacteria.
    Alahari A; Trivelli X; Guérardel Y; Dover LG; Besra GS; Sacchettini JC; Reynolds RC; Coxon GD; Kremer L
    PLoS One; 2007 Dec; 2(12):e1343. PubMed ID: 18094751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the cmaB gene are responsible for the absence of methoxymycolic acid in Mycobacterium bovis BCG Pasteur.
    Dubnau E; Marrakchi H; Smith I; Daffé M; Quémard A
    Mol Microbiol; 1998 Sep; 29(6):1526-8. PubMed ID: 9781890
    [No Abstract]   [Full Text] [Related]  

  • 11. The mycolic acid reductase Rv2509 has distinct structural motifs and is essential for growth in slow-growing mycobacteria.
    Javid A; Cooper C; Singh A; Schindler S; Hänisch M; Marshall RL; Kalscheuer R; Bavro VN; Bhatt A
    Mol Microbiol; 2020 Feb; 113(2):521-533. PubMed ID: 31785114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of a hydroxymycolic acid potentially involved in the synthesis of oxygenated mycolic acids of the Mycobacterium tuberculosis complex.
    Quémard A; Lanéelle MA; Marrakchi H; Promé D; Dubnau E; Daffé M
    Eur J Biochem; 1997 Dec; 250(3):758-63. PubMed ID: 9461299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The specificity of methyl transferases involved in trans mycolic acid biosynthesis in Mycobacterium tuberculosis and Mycobacterium smegmatis.
    Schroeder BG; Barry CE
    Bioorg Chem; 2001 Jun; 29(3):164-77. PubMed ID: 11437392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxygenated mycolic acids are necessary for virulence of Mycobacterium tuberculosis in mice.
    Dubnau E; Chan J; Raynaud C; Mohan VP; Lanéelle MA; Yu K; Quémard A; Smith I; Daffé M
    Mol Microbiol; 2000 May; 36(3):630-7. PubMed ID: 10844652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of a novel antimycobacterial compound, N-octanesulfonylacetamide, and its effects on lipid and mycolic acid synthesis.
    Parrish NM; Houston T; Jones PB; Townsend C; Dick JD
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1143-50. PubMed ID: 11257028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temperature-dependent regulation of mycolic acid cyclopropanation in saprophytic mycobacteria: role of the Mycobacterium smegmatis 1351 gene (MSMEG_1351) in CIS-cyclopropanation of alpha-mycolates.
    Alibaud L; Alahari A; Trivelli X; Ojha AK; Hatfull GF; Guerardel Y; Kremer L
    J Biol Chem; 2010 Jul; 285(28):21698-707. PubMed ID: 20457615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of PE11, a cell wall associated esterase, enhances the biofilm growth of Mycobacterium tuberculosis and reduces cell wall virulence lipid levels.
    Rastogi S; Singh AK; Pant G; Mitra K; Sashidhara KV; Krishnan MY
    Microbiology (Reading); 2017 Jan; 163(1):52-61. PubMed ID: 28198348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycolic acid methyltransferase, MmaA4, is necessary for thiacetazone susceptibility in Mycobacterium tuberculosis.
    Alahari A; Alibaud L; Trivelli X; Gupta R; Lamichhane G; Reynolds RC; Bishai WR; Guerardel Y; Kremer L
    Mol Microbiol; 2009 Mar; 71(5):1263-77. PubMed ID: 19183278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement for kasB in Mycobacterium mycolic acid biosynthesis, cell wall impermeability and intracellular survival: implications for therapy.
    Gao LY; Laval F; Lawson EH; Groger RK; Woodruff A; Morisaki JH; Cox JS; Daffe M; Brown EJ
    Mol Microbiol; 2003 Sep; 49(6):1547-63. PubMed ID: 12950920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards understanding the functional diversity of cell wall mycolic acids of Mycobacterium tuberculosis.
    Verschoor JA; Baird MS; Grooten J
    Prog Lipid Res; 2012 Oct; 51(4):325-39. PubMed ID: 22659327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.